Published in J Cell Mol Med on October 23, 2015
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer (2009) 18.53
Applying the principles of stem-cell biology to cancer. Nat Rev Cancer (2003) 8.95
Epithelial-mesenchymal transitions: twist in development and metastasis. Cell (2004) 7.14
The cancer stem cell: premises, promises and challenges. Nat Med (2011) 6.73
Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat Genet (2000) 5.23
Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc Natl Acad Sci U S A (1998) 5.21
Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry (1992) 4.63
Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res (2008) 4.09
Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis. Nat Genet (2003) 3.91
Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med (2010) 3.27
Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells (2009) 3.25
Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. Hepatology (2003) 2.70
Transcriptional crosstalk between TGF-β and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle (2010) 2.61
Epithelial-mesenchymal transition. J Cell Sci (2005) 2.39
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med (2007) 1.89
HNF4: a central regulator of hepatocyte differentiation and function. Hepatology (2003) 1.84
DGAT1 inhibitors as anti-obesity and anti-diabetic agents. Curr Opin Drug Discov Devel (2010) 1.45
Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids. Hepatology (2009) 1.32
Targeting Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) with small molecule inhibitors for the treatment of metabolic diseases. J Biol Chem (2011) 1.28
Inhibition of triglyceride synthesis as a treatment strategy for obesity: lessons from DGAT1-deficient mice. Arterioscler Thromb Vasc Biol (2004) 1.27
Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development. Mol Cell Biol (2001) 1.20
Snail overexpression induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells. Lab Invest (2012) 1.16
Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med (2005) 1.11
Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells. J Biol Chem (2011) 1.10
Current status of the research and development of diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors. J Med Chem (2013) 1.07
DGAT1 mutation is linked to a congenital diarrheal disorder. J Clin Invest (2012) 1.07
Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis. Cell Rep (2013) 1.06
Multiplatform single-sample estimates of transcriptional activation. Proc Natl Acad Sci U S A (2013) 1.00
Expression of integrins during liver organogenesis in humans. Hepatology (1998) 0.98
Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells. FEBS J (2012) 0.97
Phenotypic modulation of primary vascular smooth muscle cells by short-term culture on micropatterned substrate. PLoS One (2014) 0.91
Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells. J Virol (2014) 0.89
Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis. J Cell Mol Med (2012) 0.81
Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis. Hepatology (1996) 0.81
Small heterodimer partner attenuates profibrogenic features of hepatitis C virus-infected cells. Liver Int (2015) 1.43
Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers. PLoS One (2011) 1.16
Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions. Gastroenterology (2014) 0.86
Transcriptional regulation of adrenomedullin by oncostatin M in human astroglioma cells: implications for tumor invasion and migration. Sci Rep (2014) 0.79
Hepatitis C Virus Core Protein Promotes miR-122 Destabilization by Inhibiting GLD-2. PLoS Pathog (2016) 0.77
Comparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B. Yonsei Med J (2016) 0.76
Immunogenicity of MenACWY-CRM in Korean Military Recruits: Influence of Tetanus-Diphtheria Toxoid Vaccination on the Vaccine Response to MenACWY-CRM. Yonsei Med J (2016) 0.75
Clinical Factors and Viral Load Influencing Severity of Acute Hepatitis A. PLoS One (2015) 0.75
T cell immunosenescence, hypertension, and arterial stiffness. Epidemiol Health (2014) 0.75
DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses. Clin Exp Vaccine Res (2014) 0.75
Robust method for identification of prognostic gene signatures from gene expression profiles. Sci Rep (2017) 0.75
Autocrine DUSP28 signaling mediates pancreatic cancer malignancy via regulation of PDGF-A. Sci Rep (2017) 0.75